Watson Pharmaceuticals (WPI) agrees to buy privately-held generic pharmaceutical developer...

|By:, SA News Editor

Watson Pharmaceuticals (WPI) agrees to buy privately-held generic pharmaceutical developer Specifar Pharmaceuticals for €400M ($562M). (PR)